Dr. Wissam Hadri, D.O.
Dr. Wissam Hadri is a comprehensive ophthalmologist with expertise in treating glaucoma, cataracts, diabetic retinopathy, dry eyes, and macular degeneration. His passion for advancing eye care led him to found a biotech company, Jenna Therapeutics, dedicated to developing the world’s first cross-linking eye drop for keratoconus and myopia. He leveraged his background as a chemist prior to attending medical school to develop the world’s first cross-linking eye drop for keratoconus and myopia.

Dr. Hadri completed his undergraduate studies with honors at the University of Central Florida and earned his medical degree from the Lake Erie College of Osteopathic Medicine. After completing his ophthalmology residency at HCA Bayonet Point Hospital, he returned to his hometown of Kissimmee to begin his practice. In addition to his clinical work, he is deeply committed to education, serving as a clinical instructor for both medical students and ophthalmology residents.

Outside of his professional pursuits, Dr. Hadri is a proud husband and father who enjoys swimming, reading, MMA, and watching his favorite soccer team, Real Madrid.